{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:30:16Z","timestamp":1789421416037,"version":"build-2803163510"},"reference-count":12,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1016\/j.thromres.2003.12.015","type":"journal-article","created":{"date-parts":[[2004,2,7]],"date-time":"2004-02-07T10:16:18Z","timestamp":1076148978000},"page":"229-232","source":"Crossref","is-referenced-by-count":14,"title":["Oral anticoagulants as secondary prophylaxis of thrombosis in patients with polycythemia vera: a retrospective analysis of 15 patients"],"prefix":"10.1016","volume":"112","author":[{"given":"Thomas","family":"Bachleitner-Hofmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Grumbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Gisslinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2003.12.015_BIB1","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0140-6736(78)92098-6","article-title":"Vascular occlusive episodes and venous hematocrit in primary proliferative polycythemia","volume":"2","author":"Pearson","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2003.12.015_BIB2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V64.1.1.1","article-title":"Bleeding and thrombosis in the myeloproliferative disorders","volume":"64","author":"Schafer","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2003.12.015_BIB3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s002779900136","article-title":"Myeloproliferative disorders: complications, survival and causes of death","volume":"79","author":"Brodmann","year":"2000","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.thromres.2003.12.015_BIB4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1055\/s-2007-996114","article-title":"Relation of platelet abnormalities to thrombosis and hemorrhage in chronic myeloproliferative disorders","volume":"23","author":"Wehmeier","year":"1997","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2003.12.015_BIB5","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1055\/s-2007-996122","article-title":"Risk factors and prevention of vascular complications in polycythemia vera","volume":"23","author":"Barbui","year":"1997","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2003.12.015_BIB6","doi-asserted-by":"crossref","first-page":"656","DOI":"10.7326\/0003-4819-123-9-199511010-00003","article-title":"Polycythemia vera: the natural history of 1213 patients followed for 20 years","volume":"123","year":"1995","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.thromres.2003.12.015_BIB7","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1182\/blood-2001-12-0349","article-title":"Polycythemia vera: myths, mechanisms, and management","volume":"100","author":"Spivak","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2003.12.015_BIB8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3109\/10428190009148845","article-title":"Diagnosis and treatment of polycythemia vera and possible future study designs of the PVSG","volume":"36","author":"Michiels","year":"2000","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.thromres.2003.12.015_BIB9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0609.1999.tb01110.x","article-title":"The effect of interferon alpha on myeloproliferation and vascular complications in polycythemia vera","volume":"62","author":"Heis","year":"1999","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.thromres.2003.12.015_BIB10","first-page":"132","article-title":"Therapeutic recommendations in polycythemia vera based on polycythemia vera study group protocols","volume":"23","author":"Berk","year":"1986","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.thromres.2003.12.015_BIB11","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-2141.1997.362682.x","article-title":"Low-dose aspirin in polycythemia vera: a pilot study","volume":"97","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2003.12.015_BIB12","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1056\/NEJMoa035572","article-title":"Efficacy and safety of low-dose aspirin in polycythemia verra","volume":"350","author":"Landdfi","year":"2004","journal-title":"N. Engl. J. Med."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384804000040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384804000040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T15:21:43Z","timestamp":1585581703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384804000040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["S0049384804000040"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2003.12.015","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}